Non-radiographic Axial Spondyloarthritis

>

On the HCPLive non-radiographic axial spondyloarthritis page, resources on the topics of medical news and expert insight into nr-axSpA can be found. Content includes articles, interviews, videos, podcasts, and breaking news on rheumatic disease, and more.

Latest News

Upadacitinib Demonstrates Higher Rates of Adverse Events Compared with Adalimumab in PsA
Upadacitinib Demonstrates Higher Rates of Adverse Events Compared with Adalimumab in PsA

May 6th 2024

Both overall TEAEs and serious TEAEs were numerically higher in those receiving upadacitinib compared with adalimumab.

Headache | Image Credit: Matteo Vistocco/Unsplash
Headache, Migraine Burden Significant in Psoriatic Arthritis, Axial Spondyloarthritis

February 28th 2024

Better Clinical Responses for Biologic Naïve AxSpA Patients Treated with Secukinumab
Better Clinical Responses for Biologic Naïve AxSpA Patients Treated with Secukinumab

November 13th 2022

Filip Van den Bosch, MD: Upadacitinib for Non-radiographic Axial Spondyloarthritis
Filip Van den Bosch, MD: Upadacitinib for Non-radiographic Axial Spondyloarthritis

June 4th 2022

Improve Shared Decision Making Between Providers and Patients with Rheumatic Disease
Improve Shared Decision Making Between Providers and Patients with Rheumatic Disease

June 1st 2022

Video Series
Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.